REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amigpharm S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Amigpharm S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Amigpharm S.A. is based in Ecuador. The head office is in Cuenca. The company operates in the Pharmaceutical and Medicine Manufacturing industry. Amigpharm S.A. was incorporated on January 05, 2011. It currently has a total number of 3 (2023) employees. From the latest financial highlights, Amigpharm S.A. reported a net sales revenue drop of 25.31% in 2023. Over the same period, its total assets decreased by 49.55%.

Headquarters
Av. 10 de Agosto 32-74
Cuenca; Azuay;

Contact Details: Purchase the Amigpharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Amigpharm S.A. report to view the information.
Outstanding Shares:
Purchase the Amigpharm S.A. report to view the information.
Registered Capital:
Purchase the Amigpharm S.A. report to view the information.
Incorporation Date:
January 05, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
12.5%
Purchase this report to view the information.
12.5%
Company Performance
Financial values in the chart are available after Amigpharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-25.31%▼
Total operating revenue
-25.31%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-49.55%▼
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
317.87%▲
Quick Ratio
0.2%▲
Cash Ratio
-0.09%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo